:neuroscience, molecular medicine, and the therapeutic transformation of neurology
نام نخستين پديدآور
/ edited by Stephen Waxman
وضعیت نشر و پخش و غیره
محل نشرو پخش و غیره
Amsterdam ;Boston
نام ناشر، پخش کننده و غيره
: Elsevier Academic Press,
تاریخ نشرو بخش و غیره
, c2005.
مشخصات ظاهری
نام خاص و کميت اثر
x, 513 p., [24] p. of plates
ساير جزييات
: ill. (some col.) ; 29 cm.
یادداشتهای مربوط به نشر، بخش و غیره
متن يادداشت
e
یادداشتهای مربوط به کتابنامه ، واژه نامه و نمایه های داخل اثر
متن يادداشت
Includes bibliographical references and index.
یادداشتهای مربوط به مندرجات
متن يادداشت
Cellular plasticity of the adult human brain -- Harnessing endogenous stem cells for central nervous system repair -- Neuropathies-translating causes into treatments -- Inherited neuropathies -- Therapeutic potential of neurotrophic factors -- Promoting the regeneration of axons within the central nervous system -- Alzheimer's disease: clinical features, neuropathological and biochemical abnormalities, genetics, models, and experimental therapeutics -- Behavioral intervention and recovery from CNS damage -- What functional brain imaging will mean for neurology.
متن يادداشت
Seeing the brain so we can save it: the evolution of magnetic resonance -- Imaging as a clinical tool -- Advances in the acute treatment and secondary prevention of stroke -- Preserving function in acute nervous system injury -- Slowing the progression of multiple sclerosis -- The emergence of neurosurgical approaches to the treatment of epilepsy -- The neurobiology of migraine and transformation of headache therapy -- Botulinum toxins: transformation of a toxin into a treatment -- Prospects for slowing the progression of Parkinson's disease -- Current neurosurgical treatments for Parkinson's disease: where did they come from? -- Treatable peripheral neuropathies: plasma exchange, intravenous immunoglobulin, and other emerging therapies -- Molecular pharmacology and the treatment of Tourette's syndrome and attention deficit-hyperactivity disorder -- Neuroscience, molecular medicine, and new approaches to the treatment of depression and anxiety -- Genomics, proteomics, and neurology -- Neuroprotection: where are we going? -- Prospects for gene therapy for central nervous system disease -- Therapeutics development for hereditary neurological diseases -- Inherited channelopathies of the CNS: lessons for clinical neurology -- Inherited channelopathies of muscle: implications for therapy -- Transcriptional channelopathies of the nervous system: new targets for molecular medicine -- New molecular targets for the treatment of neuropathic pain -- Therapeutic transfer and regeneration of neural progenitors or neurons in gray matter of the adult brain --